Literature DB >> 16214646

Arterial blood pressure and hyperviscosity in sickle cell disease.

Cage S Johnson1.   

Abstract

Abnormal rheologic behavior of sickle cells is the result of increased viscosity of the blood caused by the polymerization of hemoglobin S and the resultant production of dense, dehydrated sickle erythrocytes. As the viscosity of sickle cells increases, there is a negative impact on blood flow, which contributes to the vascular occlusion process, the hallmark of the sickling disorders. Blood flow is directly proportional to the blood pressure and inversely proportional to the blood viscosity. Blood flow has important implications for the diagnosis and management of hypertension in sickle cell patients and for transfusion therapy for the acute and chronic complications of this disease.

Entities:  

Mesh:

Year:  2005        PMID: 16214646     DOI: 10.1016/j.hoc.2005.08.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  11 in total

1.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

Review 2.  Sickle Cell Disease and Stroke: Diagnosis and Management.

Authors:  Courtney Lawrence; Jennifer Webb
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

3.  Sickle cell anemia: reference values of cerebral blood flow determined by continuous arterial spin labeling MRI.

Authors:  M Arkuszewski; J Krejza; R Chen; E R Melhem
Journal:  Neuroradiol J       Date:  2013-05-10

4.  The association of optimism and perceived discrimination with health care utilization in adults with sickle cell disease.

Authors:  Michael V Stanton; Charles R Jonassaint; Frederick B Bartholomew; Christopher Edwards; Laura Richman; Laura DeCastro; Redford Williams
Journal:  J Natl Med Assoc       Date:  2010-11       Impact factor: 1.798

5.  Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study.

Authors:  Bindu Kanathezhath Sathi; Yilin Yoshida; Michael Raymond Weaver; Lila S Nolan; Barbara Gruner; Vinod Balasa; Talissa Altes; Carlos Leiva-Salinas
Journal:  Acta Haematol       Date:  2021-11-08       Impact factor: 3.068

6.  Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.

Authors:  Abel Makubi; Bruno P Mmbando; Enrico M Novelli; Johnson Lwakatare; Deogratius Soka; Harvest Marik; Kemi Tibarazwa; Mariam Ngaeje; Charles R Newton; Mark T Gladwin; Julie Makani
Journal:  Br J Haematol       Date:  2016-09-21       Impact factor: 6.998

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  In silico biophysics and hemorheology of blood hyperviscosity syndrome.

Authors:  Elahe Javadi; Yixiang Deng; George Em Karniadakis; Safa Jamali
Journal:  Biophys J       Date:  2021-06-02       Impact factor: 3.699

9.  Neck circumference is independently associated with relative systemic hypertension in young adults with sickle cell anaemia.

Authors:  Lawrence A Olatunji; Olatunde P Olabode; Olawale M Akinlade; Abiola S Babatunde; Victoria A Olatunji; Ayodele O Soladoye
Journal:  Clin Hypertens       Date:  2018-02-16

10.  Male gender, increased blood viscosity, body mass index and triglyceride levels are independently associated with systemic relative hypertension in sickle cell anemia.

Authors:  Yann Lamarre; Marie-Laure Lalanne-Mistrih; Marc Romana; Nathalie Lemonne; Daniele Mougenel; Xavier Waltz; Benoît Tressières; Maryse Etienne-Julan; Vanessa Tarer; Marie-Dominique Hardy-Dessources; Philippe Connes
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.